• 제목/요약/키워드: missense mutation

검색결과 137건 처리시간 0.023초

A Korean boy with atypical X-linked adrenoleukodystrophy confirmed by an unpublished mutation of ABCD1

  • Jwa, Hye Jeong;Lee, Keon Su;Kim, Gu Hwan;Yoo, Han Wook;Lim, Han Hyuk
    • Clinical and Experimental Pediatrics
    • /
    • 제57권9호
    • /
    • pp.416-419
    • /
    • 2014
  • X-linked adrenoleukodystrophy (X-ALD) is a rare peroxisomal disorder, that is rapidly progressive, neurodegenerative, and recessive, and characteristically primary affects the central nervous system white matter and the adrenal cortex. X-ALD is diagnosed basaed on clinical, radiological, and serological parameters, including elevated plasma levels of very long chain fatty acids (VLCFA), such as C24:0 and C26:0, and high C24:0/C22:0 and C26:0/C22:0 ratios. These tests are complemented with genetic analyses. A 7.5-year-old boy was admitted to Department of Pediatrics, Chungnam National University Hospital with progressive weakness of the bilateral lower extremities. Brain magnetic resonance imaging confirmed clinically suspected ALD. A low dose adrenocorticotropic hormone stimulation test revealed parital adrenal insufficiency. His fasting plasma levels of VLCFA showed that his C24:0/C22:0 and C26:0/C22:0 ratios were significantly elevated to 1.609 (normal, 0-1.390) and 0.075 (normal, 0-0.023), respectively. Genomic DNA was extracted from peripheral whole blood samples collected from the patient and his family. All exons of ABCD1 gene were amplified by polymerase chain reaction (PCR) using specific primers. Amplified PCR products were sequenced using the same primer pairs according to the manufacturer's instructions. We identified a missense mutation (p.Arg163Leu) in the ABCD1 gene of the proband caused by the nucleotide change 488G>T in exon 1. His asymptomatic mother carried the same mutation. We have reported an unpublished mutation in the ABCD1 gene in a patient with X-ALD, who showed increased ratio of C24:0/C22:0 and C26:0/C22:0, despite a normal VLCFA concentrations.

A novel FBN1 gene mutation associated with early-onset pneumothorax in Marfan syndrome

  • Park, Min Ji;Lee, Dong Hun;Shin, Young Lim;Hong, Yong Hee
    • Journal of Genetic Medicine
    • /
    • 제13권1호
    • /
    • pp.41-45
    • /
    • 2016
  • Marfan syndrome (MFS) is an inherited connective tissue disorder with a mutation in the fibrillin-1 (FBN1) gene. Fibrillin is a major building block of microfibrils, which constitute the structural component of the connective tissues. A 10-year-old girl visited our hospital with the chief complaint of precocious puberty. According to her medical history, she had a pulmonary wedge resection for a pneumothorax at 9 years of age. There was no family history of MFS. Mid parental height was 161.5 cm. The patient's height was 162 cm (>97th percentile), and her weight was 40 kg (75th-90th percentile). At the time of initial presentation, her bone age was approximately 11 years. From the ophthalmologic examination, there were no abnormal findings except myopia. There was no wrist sign. At the age of 14 years, she revisited the hospital with the chief complaint of scoliosis. Her height and weight were 170 cm and 50 kg, respectively, and she had arachnodactyly and wrist sign. We performed an echocardiograph and a test for the FBN1 gene mutation with direct sequencing of 65 coding exons, suspecting MFS. There were no cardiac abnormalities including mitral valve prolapse. A cytosine residue deletion in exon 7 (c.660delC) was detected. This is a novel mutation causing a frameshift in protein synthesis and predicted to create a premature stop codon. We report the case of a patient with MFS with a novel FBN1 gene missense mutation and a history of pneumothorax at a young age without cardiac abnormalities during her teenage years.

Integrative Profiling of Alternative Splicing Induced by U2AF1 S34F Mutation in Lung Adenocarcinoma Reveals a Mechanistic Link to Mitotic Stress

  • Kim, Suyeon;Park, Charny;Jun, Yukyung;Lee, Sanghyuk;Jung, Yeonjoo;Kim, Jaesang
    • Molecules and Cells
    • /
    • 제41권8호
    • /
    • pp.733-741
    • /
    • 2018
  • Mutations in spliceosome components have been implicated in carcinogenesis of various types of cancer. One of the most frequently found is U2AF1 S34F missense mutation. Functional analyses of this mutation have been largely limited to hematological malignancies although the mutation is also frequently seen in other cancer types including lung adenocarcinoma (LUAD). We examined the impact of knockdown (KD) of wild type (wt) U2AF1 and ectopic expression of two splice variant S34F mutant proteins in terms of alternative splicing (AS) pattern and cell cycle progression in A549 lung cancer cells. We demonstrate that induction of distinct AS events and disruption of mitosis at distinct sub-stages result from KD and ectopic expression of the mutant proteins. Importantly, when compared with the splicing pattern seen in LUAD patients with U2AF1 S34F mutation, ectopic expression of S34F mutants but not KD was shown to result in common AS events in several genes involved in cell cycle progression. Our study thus points to an active role of U2AF1 S34F mutant protein in inducing cell cycle dysregulation and mitotic stress. In addition, alternatively spliced genes which we describe here may represent novel potential markers of lung cancer development.

A Case of Nephrogenic Diabetes Insipidus with a Rare X-linked Recessive Mutation in an Infant with Developmental and Growth Retardation Tracked by the Korean National Health Screening Program

  • Kim, Min-Ji;Cho, Jae Young;Park, Ji Sook;Park, Eun Sil;Seo, Ji-Hyun;Lim, Jae-Young;Woo, Hyang-Ok;Youn, Hee-Shang
    • Childhood Kidney Diseases
    • /
    • 제24권2호
    • /
    • pp.131-137
    • /
    • 2020
  • Nephrogenic diabetes insipidus (DI) is a rare disease in which the patient cannot concentrate urine despite appropriate or high secretion of antidiuretic hormone. Congenital nephrogenic DI is caused by the arginine vasopressin receptor 2 (AVPR2) or aquaporin 2 (AQP2) gene mutation; the AVPR2 genetic mutation accounts for 90% of the cases. National health screening for infants and children was launched in 2007 in order to prevent accidents and promote public health in infants and children in Korea. The program has been widely used as a primary clinical service in Korea. We treated an infant with faltering growth and delayed development detected by the National health screening program, and diagnosed the problem as nephrogenic DI caused by a rare missense mutation of c.490T>C on the AVPR2 gene. This case can be a good educational nephrogenic DI with a rare AVPR2 mutation, which was well screened and traced by the national health screening program for infants and children in Korea.

pncA 유전자의 염기 서열 결정에 의한 결핵균의 Pyrazinamide 내성 진단 (Detection of Pyrazinamide Resistance in Mycobacterium Tuberculosis by Sequencing of pncA Gene)

  • 황지윤;곽경록;박혜경;이지석;박삼석;김윤성;이정유;장철훈;이민기;박순규
    • Tuberculosis and Respiratory Diseases
    • /
    • 제50권1호
    • /
    • pp.94-105
    • /
    • 2001
  • 연구배경 : Pyrazinamide(PZA)는 결핵의 1차 치료 약제이며, 산성 환경 하에서만 작용하기 때문에 in vitro에서 생물학적인 감수성 검사를 하는 것이 어렵다. pncA는 PZase를 생성하는 유전자로 이의 돌연변이가 결핵균의 PZase 활성을 소실시켜 결핵균이 PZA에 대해서 내성을 획득하게 되는 기전으로 추정된다. 본 연구에서는 PZA의 생물학적 감수성, PZase 활성 및 pncA 유전자의 돌연변이 사이의 관계를 검토하고, 아울러 결핵균의 pncA 의 염기서열 결정이 PZA 내성을 예측하는데 이용될 수 있는지를 알아보고자 하였다. 방법 : 폐결핵 환자의 객담에서 분리된 결핵균 28균주를 대상으로 하여, 절대농도법으로 PZA의 감수성을 검사하고, pncA 유전자의 open reading frame 전체 561 bp를 포함하는 710 bp 크기의 유전자를 선택적으로 증폭하였다. PCR 증폭 산물을 직접 염기서열 결정에 이용하였고, GenBank에서 확인한 결핵균 야생주의 pncA 염기서열과 비교하여 돌연변이 여부를 확인하였다. 결과 : PZase 활성이 있는 6균주 모두 pncA의 돌연변이가 없었으나, 1균주(16.7%)는 절대농도법에 의한 감수성 검사에서 위내성으로 나타났다. PZase 활성이 없는 22균주 중 21균주(95.5%)는 pncA의 돌연변이가 확인되었고, 생물학적 감수성 검사에서는 20균주가 PZA 내성, 1균주는 검사 불능, 1균주는 감수성을 보였다. pncA의 돌연변이의 양상(중복 1예 포함)은 promotor 지역과 pncA의 전 open reading frame에 걸쳐서 단일 염기의 치환에 의한 silent mutation 1개, missense mutation 10개, nonsense mutation 1개, 3염기가 삽입된 insertion 1개, 1~3개의 염기가 삽입된 frame shift mutation 4개, 그리고 2~2347개의 염기가 결실된 frame shift mutation 2개였다. 그리고 나머지 3균주는 모두 pncA유전자의 open reading frame 상부의 11번째 염기가 똑같이 adenine에서 guanine으로 치환되어 있었다. 결론 : pncA의 돌연변이는 결핵균의 PZase 활성의 소실에 의한 PZA 내성의 주요 기전이며, 특히 pncA 시작 codon의 상부 11 번째 위치의 염기 치환은 promotor의 돌연변이에 의한 PZA 내성의 주요 부위인 것으로 추정된다. Automatic sequencing에 의한 pncA의 염기서열 결정은 결핵균의 PZA 내성 진단을 위한 빠르고 효과적인 방법으로 이용할 수 있으며, PZA 내성 결핵균의 균주간 연관성을 규명하기 위한 역학 조사의 목적으로 이용할 수 있을 것으로 생각된다.

  • PDF

한국인에서의 페닐케톤뇨증의 유전자변이에 대한 고찰 (The Study of DNA Mutations of Phenylketonuria in Koreans)

  • 유수정;홍용희;이용화;정성철;기창석;이동환
    • Journal of Genetic Medicine
    • /
    • 제5권1호
    • /
    • pp.26-33
    • /
    • 2008
  • 목 적 : 페닐케톤뇨증은 상염색체 열성으로 유전되는 아미노산 대사질환으로 PAH와 조효소인 $BH_4$의 활성이 저하되어 발생한다. 본 연구에서는 PAH 유전자 돌연변이와 임상양상과의 연관성을 조사하였고 PAH DNA 변이의 국가간의 차이를 분석하였다. 방 법 : 페닐케톤뇨증 환자와 환자 가족의 동의하에 DNA를 말초혈액의 백혈구에서 분리하여 PAH 유전자를 PCR을 통해 증폭하여 유전자 서열을 분석하였고 PAH 돌연변이가 하나의 대립유전자에서만 발견이 되거나 없는 경우는 분석된 서열을 MLPA를 시행하여 분석을 하였다. 결 과 : 유전자 검사를 시행한 102명의 대립유전자 204개 중 199개의 돌연변이가 발견되어 97%의 검출률을 보였다. 발견된 돌연변이는 총 44가지의 유전자형으로 9개는 novel missense mutation이었고 1개는 novel splice site mutation이었다. 가장 많은 대립 유전자형은 R243Q와 $IVS4^{-1}$G>A로 각각 13.1%와 11.6%를 나타내었다. 전형적 페닐케톤뇨증에서는 R243Q와 $IVS4^{-1}$G>A가 각각 14.2%를 차지하였고 $BH_4$ 반응형 페닐케톤뇨증의 경우에는 R241C가 33.3%, 양성 고페닐알라닌혈증이 R241C가 40%에서 나타났다. $BH_4$ 반응형 페닐케톤뇨증의 경우에는 약물 치료만으로 조절이 되는 환자에서 T278I와 V388M mutation이 발견되었고 약물 치료만으로 조절이 되지 않고 식사요법을 병행해야하는 환자들에서만 K95del과 A447P의 돌연변이가 나타났다. 그리고 2004년 이전에는 동양인에게서 A259T 대립유전자 돌연변이가 발견되지 않은 것으로 보고되었으나 본 연구에서는 10.1%에서 발견되었다. 결 론 : 페닐케톤뇨증과 관련된 새로운 유전자 변이들이 발견되고 있으며 $BH_4$에 반응하는 유전자 변이들의 유전자형들이 확인되면서 PAH 유전자 분석은 페닐케톤뇨증 환자에서 진단, 유전상담, 식사 요법과 치료 계획 수립에 기여할 것이다.

  • PDF

WASP 유전자의 Exon 2에서 새로운 돌연변이를 가진 Wiskott-Aldrich 증후군의 1례 (A Case of Wiskott-Aldrich Syndrome with Novel Mutation in Exon 2 of the WASP Gene)

  • 이혁;박정인;김선영;문경희;이호근;황평한
    • Clinical and Experimental Pediatrics
    • /
    • 제48권5호
    • /
    • pp.551-556
    • /
    • 2005
  • 저자들은 혈소판 평균용적 및 혈소판 수의 감소, 심한 아토피 피부염 및 반복 감염을 임상적 증상으로 추정 진단된 WAS 환아로부터 WAS의 확진에 필수적인 분자학적 분석을 실시하여 WASP 단백질의 발현이 감소되어 있으며, WASP 유전자의 Exon 2, 번역 개시점으로부터 208번째의 염기서열 구아닌(g)이 아데닌(a)으로 변이되어 70번째 아미노산인 글라이신(Gly)이 알지닌(Arg)으로 변화된 missense 변이(G70A)를 발견하여 확진된 WAS 환자를 경험하였기에 문헌 고찰과 함께 이를 보고하는 바이다.

Nonautoimmune congenital hyperthyroidism due to p.Asp633Glu mutation in the TSHR gene

  • Cho, Won Kyoung;Ahn, Moon-Bae;Jang, Woori;Chae, Hyojin;Kim, Myungshin;Suh, Byung-Kyu
    • Annals of Pediatric Endocrinology and Metabolism
    • /
    • 제23권4호
    • /
    • pp.235-239
    • /
    • 2018
  • Most cases of congenital hyperthyroidism are autoimmune forms caused by maternal thyroid stimulating antibodies. Nonautoimmune forms of congenital hyperthyroidism caused by activating mutations of the thyrotropin receptor (TSHR) gene are rare. A woman gave birth to a boy during an emergency cesarean section at 33 weeks of gestation due to fetal tachycardia. On the 24th day of life, thyroid function tests were performed due to persistent tachycardia, and hyperthyroidism was confirmed. Auto-antibodies to TSHR, thyroid peroxidase, and thyroglobulin were not found. The patient was treated with propylthiouracil and propranolol, but hyperthyroidism was not well controlled. At 3 months of age, the patient had craniosynostosis and hydrocephalus, and underwent a ventriculoperitoneal shunt operation. Direct sequencing of the TSHR gene showed a heterozygous mutation of c.1899C>A (p.Asp633Glu) in exon 10. No mutations were discovered in any of the parents in a familial genetic study. We have reported a case of sporadic nonautoimmune congenital hyperthyroidism, by a missense mutation of the TSHR gene, for the first time in South Korea.

Mutation spectrum of NF1 gene in Korean unrelated patients with neurofibromatosis 1: Six novel pathogenic variants

  • Sung Hee Han;Eun Joo Kang;Mina Yang;Suekyeung Kim;Sang Gon Lee;Eun Hee Lee
    • Journal of Genetic Medicine
    • /
    • 제21권1호
    • /
    • pp.22-30
    • /
    • 2024
  • Purpose: Neurofibromatosis 1 (NF1) is one of the most common autosomal dominant diseases caused by heterozygous mutation in the NF1 gene. Mutation detection is complex owing to the large size of the NF1 gene, the presence of a high number of partial pseudogenes, and the great variety of mutations. We aimed to study the mutation spectrum of NF1 gene in Korean patients with NF1. Materials and Methods: We have analyzed total 69 unrelated patients who were clinically diagnosed with NF1. PCR and sequencing of the NF1 gene was performed in all unrelated index patients. Additionally, multiplex ligation-dependent probe amplification (MLPA) test of the NF1 and SPRED1 gene analysis (sequencing and MLPA test) were performed in patients with negative results from NF1 gene sequencing analysis. Results: Fifty-five different variants were identified in 60 individuals, including six novel variants. The mutations included 36 single base substitutions (15 missense and 21 nonsense), eight splicing mutations, 13 small insertion or deletions, and three gross deletions. Most pathogenic variants were unique. The mutations were evenly distributed across exon one through 58 of NF1, and no mutational hot spots were found. When fulfilling the National Institutes of Health criterion for the clinical diagnosis of NF1, the detection rate was 84.1%. Cafe-au-lait macules were observed in all patients with NF1 mutations. There is no clear relationship between specific mutations and clinical features. Conclusion: This study revealed a wide spectrum and genetic basis of patients with NF1 in Korea. Our results aim to contribute genetic management and counseling.

반복적인 구토 및 간헐적 의식 변화를 주소로 진단된 Ornithine Transcarbamylase Deficiency 여아 1례 (A Case of Ornithine Transcarbamylase Deficiency in 11-month-old Female who Presented Periodic Vomiting and Intermittent Consciousness Change)

  • 김진아;김진섭;허림;조성윤;진동규
    • 대한유전성대사질환학회지
    • /
    • 제15권3호
    • /
    • pp.165-170
    • /
    • 2015
  • 저자들은 출생 직후에서 생후 7개월까지는 특별한 과거력 없이 건강하게 지내던 여아에서 생후 11개월에 반복적인 구토 및 간헐적인 의식변화와 경련으로 시행한 검사 결과 고암모니아 혈증 및 소변 orotic acid의 증가를 통해 OTC 결핍증을 진단하고, 분자 유전자 검사로 418번째 염기인 G가 C로 치환되어 140번 아미노산이 alanine에서 proline으로 바뀌는 돌연변이(p. Ala140Pro)를 확인한 1례를 경험하였기에 보고하는 바이다. 본 증례의 돌연변이는 환아의 부모 유전자 분석 결과 정상 소견으로 de novo mutation으로 사료된다. 환아는 출생 후 수 개월간 큰 이상 없이 성장 및 발달을 보였으나 생후 7개월 경부터 주기적인 구토 증세를 보였던 지발형 OTC 결핍증에 해당한다. 진단 후 arginine 및 phenylbutylate를 지속적으로 복용하며 저단백 식이를 유지하는 보존적 치료를 지속하여 현재 발달 및 성장 속도 양호하며 일상생활에 문제없이 지내고 있다. 따라서 출생 후 수개월간 특이 질환력이 없는 환아, 특히 여아에서 주기적인 구토, 기면, 경련 및 혼수 등의 증상을 보일 때 지발형 OTC 결핍증과 같은 대사질환을 의심할 수 있어야 한다. 본 증례는 반복적인 구토 및 의식변화를 보인 기저질환 없는 11개월 여아에서 OTC 결핍증을 진단하고 즉각적인 대처를 통해 7세까지 심각한 신경학적 장애 없이 정상적인 성장과 발달을 보인 환자를 보고하는 바이다.